Nanomedicines Market
- 2026 年市場規模
- USD 408.1 Bn
- 2033 年預估規模
- USD 925.5 Bn
- 年複合成長率 CAGR
- 12.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.
Key features of the study
• This report provides in-depth analysis of the Global Nanomedicines market and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the Global Nanomedicines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market
Market Segmentation
• By Application Insights (Revenue, USD Bn, 2021 - 2033)
o Cardiovascular
o Anti-inflammatories
o Anti-infective
o Neurology
o Oncology
o Others (dental, orthopedic, urology, opthalmic).
• By Region Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Abbott Laboratories
o CombiMatrix Corporation
o Clene Nanomedicine, Inc
o Cellics Therapeutics, Inc
o Nanobiotix S.A
o Celgene Corporation
o GE Healthcare
o NanoViricides, Inc
o Johnson & Johnson
o Mallinckrodt plc
o Sirnaomics Inc
o Precision NanoSystems Inc
o Merck & Company Inc
o Nanosphere, Inc
o Pfizer Inc
o Sigma-Tau Pharmaceuticals Inc
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Application
Market Snippet, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Highlights
o Product launch
o PEST Analysis
o Technological Advancements
o Regulatory Scenario
o Mergers and Acquisitions
4. Global Nanomedicines Market, By Application, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Anti-inflammatories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others (dental, orthopedic, urology, opthalmic)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
5. Global Nanomedicines Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
o North America
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Germany
o U.K.
o France
o Spain
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o China
o Japan
o India
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Application, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
6. Competitive Landscape
o Company Profiles
Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
CombiMatrix Corporation
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Clene Nanomedicine, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cellics Therapeutics Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Nanobiotix S.A
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Celgene Corporation
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GE Healthcare
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
NanoViricides, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mallinckrodt plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sirnaomics Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Precision NanoSystems Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & Company Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Nanosphere, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sigma-Tau Pharmaceuticals Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
7. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 22 market data tables and 14 figures on “Nanomedicines Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們